86 related articles for article (PubMed ID: 2690869)
1. Augmentation of natural killer cell activity by ImuVert: a biological response modifier derived from Serratia marcescens.
Warren RP; McCall CA; Urban RW
Mol Biother; 1989; 1(3):145-51. PubMed ID: 2690869
[TBL] [Abstract][Full Text] [Related]
2. Augmentation of ADCC and cytotoxic T-cell activity with ImuVert.
Warren RP; McCall CA; Urban RW
Mol Biother; 1989; 1(6):323-7. PubMed ID: 2610951
[TBL] [Abstract][Full Text] [Related]
3. ImuVert activation of natural killer cytotoxicity and interferon gamma production via CD16 triggering.
Cunningham-Rundles S; Pearson FC
Int J Immunopharmacol; 1990; 12(6):589-98. PubMed ID: 2148737
[TBL] [Abstract][Full Text] [Related]
4. NK cells stimulated with IL-15 or CpG ODN enhance rituximab-dependent cellular cytotoxicity against B-cell lymphoma.
Moga E; Alvarez E; Cantó E; Vidal S; Rodríguez-Sánchez JL; Sierra J; Briones J
Exp Hematol; 2008 Jan; 36(1):69-77. PubMed ID: 17959301
[TBL] [Abstract][Full Text] [Related]
5. Monocyte-mediated augmentation of human natural killer cell activity: conditions, monocyte and effector cell characteristics.
Bloom ET; Babbitt JT; Kawakami K
J Immunol; 1986 Jul; 137(1):172-8. PubMed ID: 3711665
[TBL] [Abstract][Full Text] [Related]
6. beta-Endorphin augments the cytolytic activity and interferon production of natural killer cells.
Mandler RN; Biddison WE; Mandler R; Serrate SA
J Immunol; 1986 Feb; 136(3):934-9. PubMed ID: 2934481
[TBL] [Abstract][Full Text] [Related]
7. Modulation of human natural killer cell function by L-leucine methyl ester: monocyte-dependent depletion from human peripheral blood mononuclear cells.
Thiele DL; Lipsky PE
J Immunol; 1985 Feb; 134(2):786-93. PubMed ID: 3965574
[TBL] [Abstract][Full Text] [Related]
8. Interferon-beta and recombinant IL 2 can both enhance, but by different pathways, the nonspecific cytolytic potential of T3- natural killer cell-derived clones rather than that of T3+ clones.
van de Griend RJ; Ronteltap CP; Gravekamp C; Monnikendam D; Bolhuis RL
J Immunol; 1986 Mar; 136(5):1700-7. PubMed ID: 3005399
[TBL] [Abstract][Full Text] [Related]
9. Mode of in vitro augmentation of natural killer cell activity by recombinant human interleukin 2: a comparative study of Leu-11+ and Leu-11- cell populations in cord blood and adult peripheral blood.
Seki H; Ueno Y; Taga K; Matsuda A; Miyawaki T; Taniguchi N
J Immunol; 1985 Oct; 135(4):2351-6. PubMed ID: 3928745
[TBL] [Abstract][Full Text] [Related]
10. The immunosenescent phenotype in mice and humans can be defined by alterations in the natural immunity reversal by immunomodulation with oral AM3.
Villarrubia VG; Moreno Koch MC; Calvo C; González S; Alvarez-Mon M
Immunopharmacol Immunotoxicol; 1997 Feb; 19(1):53-74. PubMed ID: 9049659
[TBL] [Abstract][Full Text] [Related]
11. In vitro generation of human activated lymphocyte killer cells: separate precursors and modes of generation of NK-like cells and "anomalous" killer cells.
Burns GF; Triglia T; Werkmeister JA
J Immunol; 1984 Sep; 133(3):1656-63. PubMed ID: 6611374
[TBL] [Abstract][Full Text] [Related]
12. Natural killer cell activity in tumor-draining lymph nodes: investigations in patients with malignant melanoma and head and neck cancer.
Micksche M; Vinzenz K; Kokoschka EM; Kokoschka R
Nat Immun Cell Growth Regul; 1985; 4(6):315-27. PubMed ID: 4088287
[TBL] [Abstract][Full Text] [Related]
13. IL-4 regulation of murine lymphokine-activated killer activity in vitro. Effects on the IL-2-induced expansion, cytotoxicity, and phenotype of lymphokine-activated killer effectors.
Mulé JJ; Krosnick JA; Rosenberg SA
J Immunol; 1989 Jan; 142(2):726-33. PubMed ID: 2783444
[TBL] [Abstract][Full Text] [Related]
14. Rapid killing of actinomycin D-treated tumor cells by human mononuclear cells. I. Effectors belong to the monocyte-macrophage lineage.
Colotta F; Peri G; Villa A; Mantovani A
J Immunol; 1984 Feb; 132(2):936-44. PubMed ID: 6690624
[TBL] [Abstract][Full Text] [Related]
15. Lysis of human solid tumor cells by lymphokine-activated natural killer cells.
Itoh K; Tilden AB; Balch CM
J Immunol; 1986 May; 136(10):3910-5. PubMed ID: 3084648
[TBL] [Abstract][Full Text] [Related]
16. Augmentation of human natural killer cell activity by cyclophosphamide in vitro.
Sharma B; Vaziri ND
Cancer Res; 1984 Aug; 44(8):3258-61. PubMed ID: 6589041
[TBL] [Abstract][Full Text] [Related]
17. 2',5'-Oligoadenylate trimer core and the cordycepin analog augment the tumoricidal activity of human natural killer cells.
Black PL; Henderson EE; Pfleiderer W; Charubala R; Suhadolnik RJ
J Immunol; 1984 Nov; 133(5):2773-7. PubMed ID: 6332860
[TBL] [Abstract][Full Text] [Related]
18. [Effect of interferon-alpha (MOR-22) on human NK cell activity].
Yanagihara Y; Tochizawa S; Ishii K; Hirai Y
Gan To Kagaku Ryoho; 1986 Feb; 13(2):342-8. PubMed ID: 3947110
[TBL] [Abstract][Full Text] [Related]
19. Induction of cytolytic activity and interferon-gamma production in murine natural killer cells by polymyxins B and E.
Zhong M; Kadota Y; Shimizu Y; Gohda E
Int Immunopharmacol; 2008 Mar; 8(3):508-13. PubMed ID: 18279806
[TBL] [Abstract][Full Text] [Related]
20. Cytolytic activity of human peripheral blood leukocytes against Legionella pneumophila-infected monocytes: characterization of the effector cell and augmentation by interleukin 2.
Blanchard DK; Stewart WE; Klein TW; Friedman H; Djeu JY
J Immunol; 1987 Jul; 139(2):551-6. PubMed ID: 3496384
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
